Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-29

FDA Approved: ASCLERA — Supplemental Application (Methapharm, Inc)

View source ↗

Summary

FDA approved a supplemental application for ASCLERA (polidocanol) from Methapharm, Inc. The approval updates regulation around the product, which is used as a s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASCLERA (Polidocanol)

Snippet

SUPPL AP for ASCLERA (POLIDOCANOL)